Adapting a Hospital-at-Home Care Model to Respond to New York City's COVID-19 Crisis
- PMID: 32638355
- PMCID: PMC7361720
- DOI: 10.1111/jgs.16725
Adapting a Hospital-at-Home Care Model to Respond to New York City's COVID-19 Crisis
Conflict of interest statement
David J. Heller reports grant support from Teva Pharmaceuticals, which was not involved in any way in the conception or writing of this manuscript, the execution of the work described, or the decision to publish. Albert L. Siu serves as a board member for a joint venture between Mount Sinai and Contessa Health that manages the Mount Sinai Hospital‐at‐Home program, but he has no financial interest in this venture.
References
-
- Adalja AA, Toner E, Inglesby TV. Priorities for the US health community responding to COVID‐19. JAMA. 2020;323(14):1343‐4134. - PubMed
-
- Leff B, Burton L, Mader SL, et al. Hospital at home: feasibility and outcomes of a program to provide hospital‐level care at home for acutely ill older patients. Ann Int Med. 2005;143(11):798‐808. - PubMed
-
- Shepperd S, Iliffe S. Hospital at home versus in‐patient hospital care. Cochrane Database Sys Rev. 2005;3:CD000356. - PubMed
-
- DeCherrie LV, Wajnberg A, Soones T, et al. Hospital at home‐plus: a platform of facility‐based care. J Am Geriatr Soc. 2019;67(3):596‐602. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 AG028741/AG/NIA NIH HHS/United States
- John A. Hartford Foundation/International
- K08/AG/NIA NIH HHS/United States
- K08 AG050808/AG/NIA NIH HHS/United States
- 3P30AG028741/the John A. Hartford Foundation/International
- NIA/International
- Teva Pharmaceutical Industries/International
- AG050808/AG/NIA NIH HHS/United States
- Icahn School of Medicine at Mount Sinai/International
- West Health Institute/International
- TS 3P30AG028741/Claude D. Pepper Older Americans Independence Center, Icahn School of Medicine at Mount Sinai/International
LinkOut - more resources
Full Text Sources
Medical